SEC 13F Intelligence

Atlas Venture Life Science Advisors, LLC / AKRO

Atlas Venture Life Science Advisors, LLC’s Akero Therapeutics Inc Com Position

Does Atlas Venture Life Science Advisors, LLC own Akero Therapeutics Inc Com (AKRO)? Not currently — the last reported position was 359.3K shares worth $8M in Q4 2023; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$8M
Q4 2023
Shares
359.3K
% of Portfolio
+1.00%
Quarters Held
8
position exited

Position History AKRO

Reported value by quarter
Q1 ’22: $32MQ1 ’22Q2 ’22: $21MQ2 ’22Q3 ’22: $34MQ3 ’22Q4 ’22: $33MQ4 ’22Q1 ’23: $23MQ1 ’23Q2 ’23: $28MQ2 ’23Q3 ’23: $18MQ3 ’23Q4 ’23: $8MQ4 ’23filingsflow.com
QuarterSharesValue% of Portfolio
Q4 2023359.3K$8M+1.00%
Q3 2023359.3K$18M+2.81%
Q2 2023594.3K$28M+3.45%
Q1 2023594.3K$23M+3.08%
Q4 2022594.3K$33M+3.92%
Q3 2022994.3K$34M+3.74%
Q2 20222.23M$21M+3.53%
Q1 20222.23M$32M+4.00%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Atlas Venture Life Science Advisors, LLC’s full portfolio or all institutional holders of AKRO.